Immunic Stock Price Prediction
| IMUX Stock | USD 1.11 0.02 1.77% |
Oversold Vs Overbought
52
Oversold | Overbought |
EPS Estimate Next Quarter (0.21) | EPS Estimate Current Year (0.96) | EPS Estimate Next Year (0.76) | Wall Street Target Price 12.7857 | EPS Estimate Current Quarter (0.22) |
Using Immunic hype-based prediction, you can estimate the value of Immunic from the perspective of Immunic response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Immunic to buy its stock at a price that has no basis in reality. In that case, they are not buying Immunic because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Immunic after-hype prediction price | USD 1.16 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Immunic |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Immunic's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Immunic After-Hype Price Prediction Density Analysis
As far as predicting the price of Immunic at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Immunic or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Immunic, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Immunic Estimiated After-Hype Price Volatility
In the context of predicting Immunic's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Immunic's historical news coverage. Immunic's after-hype downside and upside margins for the prediction period are 0.06 and 5.85, respectively. We have considered Immunic's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Immunic is unstable at this time. Analysis and calculation of next after-hype price of Immunic is based on 3 months time horizon.
Immunic Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Immunic is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Immunic backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Immunic, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.46 | 4.68 | 0.00 | 0.09 | 8 Events / Month | 10 Events / Month | In about 8 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
1.11 | 1.16 | 0.00 |
|
Immunic Hype Timeline
Immunic is currently traded for 1.11. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -0.09. Immunic is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is currently at -0.46%. %. The volatility of related hype on Immunic is about 2295.85%, with the expected price after the next announcement by competition of 1.02. About 65.0% of the company shares are owned by institutional investors. The book value of Immunic was currently reported as 0.46. The company recorded a loss per share of 1.23. Immunic last dividend was issued on the 15th of April 2019. The entity had 1:40 split on the 15th of April 2019. Given the investment horizon of 90 days the next anticipated press release will be in about 8 days. Check out Immunic Basic Forecasting Models to cross-verify your projections.Immunic Related Hype Analysis
Having access to credible news sources related to Immunic's direct competition is more important than ever and may enhance your ability to predict Immunic's future price movements. Getting to know how Immunic's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Immunic may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| GBIO | Generation Bio Co | 0.21 | 4 per month | 0.00 | (0.24) | 6.36 | (8.20) | 21.16 | |
| KRON | Kronos Bio | 0.02 | 8 per month | 3.54 | 0.01 | 5.75 | (6.25) | 17.56 | |
| ERAS | Erasca Inc | (0.15) | 8 per month | 0.00 | (0.07) | 7.42 | (6.08) | 20.29 | |
| CCCC | C4 Therapeutics | (0.11) | 6 per month | 0.00 | (0.11) | 9.28 | (7.99) | 23.66 | |
| EWTX | Edgewise Therapeutics | (1.67) | 9 per month | 3.10 | 0.11 | 6.65 | (5.54) | 61.90 | |
| FHTX | Foghorn Therapeutics | (0.30) | 9 per month | 0.00 | (0.17) | 8.07 | (8.30) | 20.98 | |
| STTK | Shattuck Labs | (0.02) | 9 per month | 0.00 | (0.16) | 10.62 | (9.82) | 49.02 | |
| GLUE | Monte Rosa Therapeutics | 0.84 | 9 per month | 4.34 | 0.06 | 8.40 | (8.46) | 103.72 | |
| KYMR | Kymera Therapeutics | (1.49) | 10 per month | 0.00 | (0.04) | 5.21 | (5.65) | 18.10 | |
| NRIX | Nurix Therapeutics | 0.07 | 11 per month | 0.00 | (0.07) | 6.47 | (4.73) | 22.77 | |
| KZR | Kezar Life Sciences | (0.06) | 8 per month | 2.60 | 0.05 | 4.93 | (4.39) | 51.13 | |
| SPRB | Spruce Biosciences | 0.06 | 8 per month | 0.00 | (0.07) | 6.82 | (5.36) | 31.01 | |
| EYEN | Eyenovia | (0.05) | 10 per month | 0.00 | (0.15) | 11.86 | (19.18) | 92.81 |
Immunic Additional Predictive Modules
Most predictive techniques to examine Immunic price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Immunic using various technical indicators. When you analyze Immunic charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Immunic Predictive Indicators
The successful prediction of Immunic stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Immunic, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Immunic based on analysis of Immunic hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Immunic's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Immunic's related companies. | 2010 | 2023 | 2024 (projected) | Dividend Yield | 0.007985 | 0.007187 | 0.006388 | Price To Sales Ratio | 21.6K | 19.5K | 17.3K |
Story Coverage note for Immunic
The number of cover stories for Immunic depends on current market conditions and Immunic's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Immunic is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Immunic's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Immunic Short Properties
Immunic's future price predictability will typically decrease when Immunic's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Immunic often depends not only on the future outlook of the potential Immunic's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Immunic's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 44.3 M | |
| Cash And Short Term Investments | 46.7 M |
Additional Tools for Immunic Stock Analysis
When running Immunic's price analysis, check to measure Immunic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunic is operating at the current time. Most of Immunic's value examination focuses on studying past and present price action to predict the probability of Immunic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immunic's price. Additionally, you may evaluate how the addition of Immunic to your portfolios can decrease your overall portfolio volatility.